ARMADA ACQUISITION CORP II
- Market cap
- 720.25M
- P/E (TTM)i
- 230.30
- P/Bi
- 3.18
- EPSi
- 0.11
- Div yieldi
- 0.00%
- 52W posi
- 30%
Anonymous reader poll. Unscientific, not investment advice.
Valuation each multiple against its own 5-year range
Vs. peers Shell Companies
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| ARMADA ACQUISITION CORP II (XRPN) | 720.25M | 230.30 | 3.18 | 0.00% |
| Vylor Inc (VYLR) | 49.73B | 105.13 | 3.28 | 0.00% |
| DRUGS MADE IN AMERICA ACQ II CORP (DMII) | 649.10M | 34.90 | 1.31 | 0.00% |
| Churchill Capital Corp XI (CCXI) | 638.05M | 0.00 | 2.38 | 0.00% |
| EQV VENTURES ACQUISITION CORP. II (EVAC) | 603.18M | 14.76 | 1.31 | 0.00% |
| Bain Capital GSS Investment (BCSS) | 596.85M | 0.00 | 1.30 | 0.00% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 60.6% below Morningstar's fair value estimate.
Fair value
Armada Acquisition Corp II is assigned a 5-star quantitative star rating, illustrating our stance that this share class offers a compelling opportunity for investors. The stock currently trades at a 32% discount to our quantitative fair value estimate of $36.62 per share; however, caution is warranted due to this estimate's high uncertainty rating.
The company's liquidity bolsters our fair value estimate. Low liquidity may indicate efficient capital use and strong investment opportunities. Reflecting the firm's liquidity is its median trading volume over the past 60 days, which sits in the bottom 40% globally. Relatively low trading volume for these shares could lead to prices that don't accurately reflect the intrinsic value of shares. We believe this is a sign that shares could be cheap.
On a different note, the company's valuation metrics are potentially concerning. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's book value yield of 18.2%, for example, ranks in the bottom 20% globally. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which, despite our favorable price/fair value ratio, is a negative attribute.
Economic moat
The company's narrow economic moat rating suggests it should be able to maintain robust profitability for a decade or longer before competition erodes its advantage. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.
By Quantitative Equity Report
Quote time 2026-10-08 10:11:33 · For reference only, not investment advice and not tailored to your situation.